Reports for BAXTER CORPORATION
Company Name
BAXTER CORPORATION
Totals |
||
Shortage reports |
191 |
|
| Actual shortage: | 2 (1%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 3 (2%) | |
| Resolved: | 186 (97%) | |
Discontinuation Reports |
30 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 29 (97%) | |
| Reversed: | 1 (3%) | |
Late reports |
9 (4%) |
|
Overdue reports |
1 (50%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| HEPARIN SOD AND 0.9% SOD CHLORIDE INJ | 9MG 2UNIT | SOLUTION | Resolved | 2019-10-04 | 2020-01-07 | 95570 |
| 0.4% LIDOCAINE HYDROCHLORIDE AND 5% DEXTROSE INJECTION | 50MG 4MG | SOLUTION | Resolved | 2019-12-19 | 2020-01-28 | 101629 |
| IFEX | 3G | POWDER FOR SOLUTION | Resolved | 2020-01-16 | 2020-02-05 | 103465 |
| 5% DEXTROSE INJECTION, USP | 5G | SOLUTION | Resolved | 2020-01-17 | 2020-02-11 | 103477 |
| PROPOFOL | 10MG | EMULSION | Resolved | 2020-01-17 | 2020-02-12 | 103474 |
| 0.9% SODIUM CHLORIDE IRRIGATION, USP | 900MG | SOLUTION | Resolved | 2020-02-13 | 2020-03-10 | 106077 |
| 5% DEXTROSE INJECTION, USP | 5G | SOLUTION | Resolved | 2020-03-10 | 2020-03-21 | 108434 |
| HEPARIN SOD AND 0.9% SOD CHLORIDE INJ | 9MG 2UNIT | SOLUTION | Resolved | 2020-01-28 | 2020-03-21 | 104484 |
| 5% DEXTROSE INJECTION, USP | 5G | SOLUTION | Resolved | 2020-03-12 | 2020-04-08 | 108635 |
| IFEX | 3G | POWDER FOR SOLUTION | Resolved | 2020-04-02 | 2020-04-21 | 110477 |
| PROPOFOL | 10MG | EMULSION | Resolved | 2020-03-24 | 2020-04-25 | 109301 |
| DOPAMINE HCL 0.8MG/ML DEXTROSE 5% INJ USP | .8MG 50MG | SOLUTION | Resolved | 2020-04-06 | 2020-05-02 | 111045 |
| IFEX | 1G | POWDER FOR SOLUTION | Resolved | 2020-04-23 | 2020-05-13 | 113046 |
| PROPOFOL INJECTION | 10MG | EMULSION | Resolved | 2018-03-23 | 2020-06-10 | 43857 |
| PROPOFOL INJECTION | 10MG | EMULSION | Resolved | 2018-03-19 | 2020-06-10 | 43360 |
| IFEX | 3G | POWDER FOR SOLUTION | Resolved | 2020-06-08 | 2020-06-23 | 116977 |
| PLASMA-LYTE A INJECTION | 526MG 368MG 502MG 37MG 30MG | SOLUTION | Resolved | 2020-08-17 | 2020-08-18 | 122377 |
| PLASMA-LYTE A INJECTION | 526MG 368MG 502MG 37MG 30MG | SOLUTION | Resolved | 2020-08-17 | 2020-09-01 | 122375 |
| IFEX | 1G | POWDER FOR SOLUTION | Resolved | 2020-08-27 | 2020-09-02 | 123045 |
| CLINDAMYCIN INJECTION IN 5% DEXTROSE | 600MG | SOLUTION | Resolved | 2020-09-02 | 2020-09-17 | 123592 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| SELECTBAG ONE (AX050G) | 44.1G 20.3G 36G 220G | SOLUTION | Discontinued | 2020-10-08 | 2020-11-01 | 125971 |
| SELECTBAG ONE (AX275G) | 36.0G 220.0G 51.5G 29.8G 20.3G | SOLUTION | Discontinued | 2020-10-07 | 2020-12-18 | 125887 |
| POTASS CHLOR 40MEQ 5% DEX AND 0.9% SOD CHLOR | 5G 900MG 300MG | SOLUTION | Discontinued | 2020-11-26 | 2021-02-02 | 128947 |
| CLINIMIX E | 90MG 210MG 20MG 261MG 58.5MG 24MG 205MG 20G 310MG 310MG 290MG 290MG 1.04G 1.04G 520MG 240MG 230MG 220MG 210MG | SOLUTION | Discontinued | 2020-06-22 | 2021-03-26 | 118604 |
| CLINIMIX | 240MG 210MG 90MG 1.04G 575MG 340MG 250MG 515MG 20MG 10G 365MG 280MG 290MG 200MG 300MG 290MG | SOLUTION | Discontinued | 2020-06-22 | 2022-04-20 | 118601 |
| CLINIMIX E | 205MG 261MG 58.5MG 24MG 16.6G 365MG 280MG 290MG 200MG 300MG 290MG 240MG 210MG 90MG 1.04G 575MG 340MG 250MG 515MG 20MG | SOLUTION | Discontinued | 2020-06-22 | 2022-06-30 | 118607 |
| SELECTBAG ONE (AX2525G) | 36.8G 37.3G 20.3G 36.0G 220.0G | SOLUTION | Reversed | 2020-10-07 | 2022-07-19 | 125880 |
| CLINIMIX | 200MG 300MG 290MG 240MG 210MG 90MG 1.04G 575MG 340MG 250MG 515MG 20MG 16.6G 365MG 280MG 290MG | SOLUTION | Discontinued | 2020-06-22 | 2022-12-08 | 118612 |
| 1.6% SODIUM CHLORDIE PROCESSING SOLUTION | 1.6G | SOLUTION SOLUTION | Discontinued | 2022-12-13 | 2023-01-01 | 178273 |
| CLINDAMYCIN INJECTION IN 5% DEXTROSE | 300MG | SOLUTION | Discontinued | 2023-02-06 | 2023-04-02 | 183710 |